These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36166244)

  • 1. FGF23: From academic nephrology to personalized patients' care.
    González-Casaus ML; Gonzalez-Parra E; Fernandez-Calle P; Buño-Soto A
    Nefrologia (Engl Ed); 2021; 41(3):276-283. PubMed ID: 36166244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23: from academic nephrology to personalized patient́s care.
    González-Casaus ML; Gonzalez-Parra E; Fernandez-Calle P; Buño-Soto A
    Nefrologia (Engl Ed); 2021; 41(3):276-283. PubMed ID: 33422302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis.
    Mace ML; Olgaard K; Lewin E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
    Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klotho/FGF23 Axis in CKD.
    Tsuchiya K; Nagano N; Nitta K
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
    Yamada S; Giachelli CM
    Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
    Xie J; Yoon J; An SW; Kuro-o M; Huang CL
    J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23.
    Navarro-García JA; Salguero-Bodes R; González-Lafuente L; Martín-Nunes L; Rodríguez-Sánchez E; Bada-Bosch T; Hernández E; Mérida-Herrero E; Praga M; Solís J; Arribas F; Bueno H; Kuro-O M; Fernández-Velasco M; Ruilope LM; Delgado C; Ruiz-Hurtado G
    BMC Med; 2022 Jan; 20(1):14. PubMed ID: 35042527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on fibroblast growth factor 23 in chronic kidney disease.
    Wolf M
    Kidney Int; 2012 Oct; 82(7):737-47. PubMed ID: 22622492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of FGF23 in CKD--with or without Klotho.
    Komaba H; Fukagawa M
    Nat Rev Nephrol; 2012 Jun; 8(8):484-90. PubMed ID: 22714041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
    Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor 23 and Klotho Are Associated With Trabecular Bone Score but Not Bone Mineral Density in the Early Stages of Chronic Kidney Disease: Results of the Cross-Sectional Study.
    Kužmová Z; Kužma M; Gažová A; Kovářová M; Jackuliak P; Killinger Z; Kyselovič J; Payer J
    Physiol Res; 2021 Nov; 70(Suppl 1):S43-S51. PubMed ID: 35503049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
    de Seigneux S; Martin PY
    Pharmacol Res; 2016 Apr; 106():87-91. PubMed ID: 26900884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF23 and Klotho in chronic kidney disease.
    Olauson H; Larsson TE
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
    Hong YA; Lim JH; Kim MY; Kim Y; Yang KS; Chung BH; Chung S; Choi BS; Yang CW; Kim YS; Chang YS; Park CW
    Clin Exp Nephrol; 2015 Apr; 19(2):208-15. PubMed ID: 24682550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.
    Sakan H; Nakatani K; Asai O; Imura A; Tanaka T; Yoshimoto S; Iwamoto N; Kurumatani N; Iwano M; Nabeshima Y; Konishi N; Saito Y
    PLoS One; 2014; 9(1):e86301. PubMed ID: 24466013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.